Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.60
+0.33 (6.26%)
At close: May 12, 2025, 4:00 PM
5.77
+0.17 (3.04%)
After-hours: May 12, 2025, 6:49 PM EDT
Abeona Therapeutics Employees
Abeona Therapeutics had 136 employees as of December 31, 2024. The number of employees increased by 52 or 61.90% compared to the previous year.
Employees
136
Change (1Y)
52
Growth (1Y)
61.90%
Revenue / Employee
n/a
Profits / Employee
-$468,632
Market Cap
271.79M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ABEO News
- 18 hours ago - Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million - GlobeNewsWire
- 5 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 12 days ago - Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease - Benzinga
- 13 days ago - US FDA approves Abeona's skin disorder therapy - Reuters
- 13 days ago - U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) - GlobeNewsWire
- 15 days ago - Undercovered Dozen: 3D Systems, Seritage, Topicus, Timken + - Seeking Alpha
- 21 days ago - Pz-Cel Has Massive Potential For RDEB Patients - Seeking Alpha
- 4 weeks ago - Abeona Therapeutics: A Buy With Major PDUFA Catalyst On April 29 That Should Send Shares Higher - Seeking Alpha